Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus

✍ Scribed by Nikolaos P.E. Kadoglou; Fotios Iliadis; Nikolaos Sailer; Zoi Athanasiadou; Ioulia Vitta; Alikistis Kapelouzou; Panayotis E. Karayannacos; Christos D. Liapis; Miltiadis Alevizos; Nikoletta Angelopoulou; Ioannis S. Vrabas

• Book ID: 113798932
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 315 KB
• Volume: 59
• Category: Article
• ISSN: 1532-8600
• DOI: 10.1016/j.metabol.2009.09.002